30 May2024Vesper Bio Announces Completion of Single Ascending Dose Stage In Trial of Its Lead Candidate VES001, A Potentially Disease-Modifying Treatment For Fronto-Temporal DementiaAuthor By Healthufit Posted on May 30, 2024May 30, 2024Vesper Bio Announces Completion of Single Ascending Dose Stage In Trial of...
08 Apr2024Vivet Therapeutics Doses First Patient In Cohort 2 In Phase 1/2 GATEWAY Clinical Trial For Treatment Of Wilson DiseaseAuthor By Healthufit Posted on April 8, 2024April 8, 2024Vivet Therapeutics Doses First Patient In Cohort 2 In Phase 1/2 GATEWAY Cli...